Vertex Pharmaceutica
VRTX
Delayed Nasdaq - 01/16 10:00:00 pm
155.71USD
-1.41%
Prev.157.9300
Open158.2800
High159.8700
Low155.1400
Volume1 834 799
Last news
Financials
Sales 2017 2 333 M
EBIT 2017 538 M
R. net 2017 294 M
Tréso. 2017 902 M
Rend. 2017 -
P/E ratio 2017 155,34
P/E ratio 2018 84,19
EV / Sales 2017 16,5x
EV / Sales 2018 13,9x
Capitalization 39 380 M
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including...
Sector :
Bio Therapeutic Drugs
Calendar :
2018-01-31 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBullish
Resistance158166163
Spread/Res.-1,7%-6,3%-4,6%
Spread/Supp.6,8%13%32%
Support146137118